Hongtai Aplus
Beijinghongtaifund.com
Overview
Hongtai Aplus is an investment firm founded in 2014 that focuses on venture capital and fund of fund investments across China, with a focus on information technology, advanced manufacturing, pharmacy & medical care, consumption & education, and new materials.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Accro Bioscience Inc. | Jan 2022 | Series B | Lead |
| KKV | Aug 2020 | Series E | Co-investor |
| Luoji Siwei | Sep 2017 | Series D | Co-investor |
| Shinehigh Innovation | - | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.